Company Profile

Immune Modulatory Therapies LLC
Profile last edited on: 1/24/20      CAGE: 7F0L2      UEI: J453G5R8UMJ5

Business Identifier: Therapies that modulate the body's immune system
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

Eden, NY 14057
   (716) 713-5772
Location: Single
Congr. District: 27
County: Erie

Public Profile

Immune Modulatory Therapies LLC is developing therapies that modulate the body's immune system. The firm's technologies reduce the body's immune response to specific tissues, thus reducing the effect of autoimmune diseases. The firm also is working on modulating the body's response to specific drugs, making these drugs less toxic and more effective over time.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $293,178
Project Title: Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine
2018 1 NIH $280,928
Project Title: Reversing/Blocking T Cell Suppression by Extracellular Vesicles as Cancer Therapy

Key People / Management

  Maulasri Bhatta

Company News

There are no news available.